TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
INNOVATORS with Jane King – interviewing CEO Glenn Mattes
& Dr. Bill Williams - Professor at Univ. of Texas – Austin
At the NASDAQ Market Site, Nov. 20, 2019
TFF Pharmaceuticals’ Scientific Consultant Robert O. Williams III Named to National Academy of Inventors
January 7, 2020
TFF Pharmaceuticals to Meet with Investors and Commercial Partners in San Francisco during the JP Morgan Healthcare Conference
December 11, 2019
December 9, 2019